- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 57/15 - Fumaric acid
Patent holdings for IPC class C07C 57/15
Total number of patents in this class: 244
10-year publication summary
19
|
6
|
23
|
12
|
18
|
9
|
13
|
16
|
20
|
20
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 10730 |
11 |
Purac Biochem B.V. | 483 |
9 |
Caamtech, Inc. | 146 |
8 |
Gilead Sciences, Inc. | 2045 |
5 |
Integrative Research Laboratories Sweden AB | 36 |
5 |
Teva Pharmaceuticals USA, Inc. | 881 |
5 |
R.J. Reynolds Tobacco Company | 504 |
4 |
University Health Network | 1048 |
4 |
SyneuRx International (Taiwan) Corp. | 44 |
4 |
Genentech, Inc. | 3994 |
3 |
Merck Patent GmbH | 5824 |
3 |
Actavis Group PTC ehf | 440 |
3 |
Apotex Inc. | 204 |
3 |
Armgo Pharma, Inc. | 13 |
3 |
Assia Chemical Industries Ltd. | 187 |
3 |
Blueprint Medicines Corporation | 238 |
3 |
Daewoong Pharmaceutical Co., Ltd. | 321 |
3 |
Totus Medicines Inc. | 23 |
3 |
Inspirna, Inc. | 38 |
3 |
Amgen Inc. | 4106 |
2 |
Other owners | 157 |